Yazhou Li

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 851 citations · Full text

Medicine, Neurology, Pharmacology +12

Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis

Yazhou Li, Tanya Hansotia, Bernardo Yusta et al. · Journal of Biological Chemistry · 2002 · 590 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

Yazhou Li, TracyAnn Perry, Mark S. Kindy et al. · Proceedings of the National Academy of Sciences · 2009 · 576 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Yazhou Li, Kara B. Duffy, Mary Ann Ottinger et al. · Journal of Alzheimer s Disease · 2010 · 324 citations

Medicine, Endocrinology, Neuroscience +17

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati et al. · JAMA Neurology · 2019 · 256 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17